/주식/TKNO
TKNO

TKNO

USD

Alpha Teknova Inc. Common Stock

$6.520-0.240 (-3.550%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$6.760

고가

$6.850

저가

$6.500

거래량

0.03M

기업 기본 정보

시가총액

348.4M

산업

Drug Manufacturers - Specialty & Generic

국가

United States

거래 통계

평균 거래량

0.45M

거래소

NGM

통화

USD

52주 범위

저가 $1.155현재가 $6.520고가 $10.37

AI 분석 리포트

마지막 업데이트: 2025년 5월 2일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

TKNO (Alpha Teknova Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: TKNO Generate Date: 2025-05-02 17:05:32

Alright, let's break down what's happening with Alpha Teknova, ticker symbol TKNO. Think of this as looking under the hood to see what the recent news, price action, and some AI predictions might suggest.

The Latest Buzz: Earnings on the Horizon

The main piece of news we've got is pretty straightforward: Teknova plans to announce their first-quarter financial results on May 8th. This isn't news about a big new product or a problem, just a date for sharing their report card.

Why does this matter? Well, earnings reports are a big deal for any stock. They give investors a look at how the company is actually doing – are they making more money? Less? Are their costs under control? The numbers they report, and what the company says about the future, can really move the stock price, sometimes quite a bit. So, that May 8th date is definitely one to circle if you're watching TKNO.

Interestingly, some AI analysis points to recent news sentiment being quite positive overall, even with this specific announcement being neutral on its face. This could mean there's been other positive chatter or anticipation building around these upcoming results.

Checking the Price Tag: What the Chart Shows

Looking back over the last few months, TKNO's stock price has been on a bit of a rollercoaster. It started off around the $8-$9 mark back in February, but then saw a pretty significant slide, dipping down into the $5-$6 range by early March.

Since hitting those lows, the price has shown signs of life. It's been gradually climbing back up, though with some ups and downs along the way. Lately, it's been trading in the mid-$6 range, recovering some ground from those earlier dips. The current price is sitting right around $6.68.

Now, what about the very near future? An AI model is predicting a slight upward nudge for the stock over the next couple of days, suggesting potential gains of around 3% or so. This aligns with the recent trend of recovery we've seen.

Putting It Together: What Does This All Suggest?

Based on the information at hand – the upcoming earnings report acting as a potential catalyst, the stock's recent bounce back from lower levels, and the AI's short-term positive forecast – the near-term picture seems to lean cautiously positive.

Here's the thinking: The stock has already taken a hit and is now showing some upward momentum. The earnings report is the next big event, and if the numbers are good or the outlook is promising, that could fuel further gains. The AI prediction supports the idea of some upward movement happening soon.

Potential Strategy Ideas (Just things to think about, not advice!):

  • If you're considering getting in: The current price area, around $6.70, looks like a potential spot that some analysis points to. You might consider if this level makes sense for you, perhaps keeping the upcoming earnings date in mind – sometimes waiting until after the report gives more clarity, though you risk missing a move if the news is good.
  • Managing Risk: If you do decide to jump in, having a plan for when to get out is smart. A potential stop-loss level to consider, based on some analysis, might be around $5.96. This is below some recent trading lows and could help limit potential losses if the stock turns south unexpectedly.
  • Thinking About Taking Profits: If the stock does move up, a potential target level mentioned is around $7.12. This could be a point to consider selling some or all of your shares to lock in gains.

Remember, these are just potential levels based on the data provided; the market can do anything!

A Little About the Company

Alpha Teknova is in the healthcare sector, specifically making important stuff (reagents) that other companies use to discover and develop new medicines, vaccines, and diagnostic tests. They serve labs, pharma companies, and research institutions.

It's worth noting that TKNO is considered a smaller company (its market value is around $357 million) and its stock doesn't trade a massive amount of shares every day compared to bigger companies. This can sometimes mean bigger price swings on less news. Also, like many companies focused on growth in this sector, they aren't currently profitable, which is reflected in their negative P/E ratio – though the provided data suggests their P/E is better than the average for their specific industry group. They also carry a fair bit of debt relative to their size.

The upcoming earnings report will shed more light on their financial health and growth trajectory, which is key for a company like this.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

GlobeNewswire

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies,

더 보기
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 5월 4일 오후 08:11

약세중립강세

77.6% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$6.62

익절

$7.06

손절

$5.88

핵심 요소

RSI 24.4은(는) 과매도 상태를 나타내며 잠재적인 강력한 반전을 시사합니다.
K 값 18.3은(는) D 값 21.2보다 낮고 20 미만이므로 과매도 상태를 시사합니다.
DMI는 약세 추세(ADX:22.5, +DI:5.7, -DI:17.7)를 보여 주의를 요합니다.
현재 가격이 지지선($6.59)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(5,866)의 3.4배로 극도로 강력한 매수 압력을 나타냅니다.
MACD -0.0345이(가) 신호선 -0.0231 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기